Skip to contentG
Gossamer Bio, Inc.
G
GOSSGossamer Bio, Inc. Q3 2023 · 10-Q
Revenue$0.00$0.00no prior Q3 2022 on file Net Income-$40.01M-$40.01MN/M vs Q3 2022 EPS Diluted-$0.21-$0.21N/M vs Q3 2022 Operating Income-$40,490,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$34,494,000N/M ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end